Ipamorelin
-16%
4X Tested - ISO 17025
99.89% View COA
Growth Peptide

Ipamorelin

Certificate of Analysis

Ipamorelin is a selective synthetic pentapeptide growth hormone secretagogue that targets the ghrelin receptor to stimulate growth hormone release in preclinical and clinical research models.

BUNDLE & SAVE
2-Day Shipping

Free Shipping
over $200

Free shipment
protection

Secure Checkout
256-bit SSL

Description

What is Ipamorelin?

Ipamorelin is a synthetic pentapeptide composed of five amino acids. It acts as a selective agonist of the ghrelin/growth hormone secretagogue receptor (GHS-R), making it one of the most studied peptides in growth hormone research.

What distinguishes Ipamorelin from other growth hormone secretagogues is its high selectivity. In preclinical studies, it has demonstrated the ability to stimulate growth hormone release without significantly affecting cortisol, prolactin, or other hormones, a characteristic that has made it a preferred tool in endocrine research.

Ipamorelin has been studied in Phase II clinical trials for postoperative ileus (delayed gastric emptying), though those trials were discontinued due to lack of efficacy for that specific indication. Research continues in areas including bone density, body composition, and growth hormone pulsatility.

Ipamorelin is not approved by the FDA for any medical use. All products are sold strictly for laboratory and research purposes only.

Research Applications

Areas of Investigation
GH Release

Growth Hormone Secretion

Studied as a selective GHS receptor agonist for its ability to stimulate pulsatile growth hormone release without significantly affecting cortisol or prolactin.
Bone Health

Bone Density Research

Investigated in preclinical models for its potential effects on bone mineral content and longitudinal bone growth.
Metabolism

Body Composition

Researched for effects on lean mass and fat distribution in growth hormone-related studies.
Gut Function

Gastrointestinal Motility

Evaluated in Phase II clinical trials for its effects on gastric emptying and postoperative ileus.

Compound Profile

Technical specifications
What is Ipamorelin?

Molecular Profile

Sequence
XH-z-f-K-NH₂
Molecular Formula
C₃₈H₄₉N₉O₅
Molecular Weight
711.86 g/mol
Appearance
White lyophilized powder

Form

Lyophilized (freeze-dried)
Handling & Shelf Life Guidelines

Storage & Stability

Storage (Pre-Reconstitution)

Store below -18°C, desiccated, away from light and moisture. Stable at room temperature for up to 3 weeks.
Storage (Post-Reconstitution)
Refrigerate at 2–8°C. For longer storage, aliquot and store below -18°C. Avoid freeze-thaw cycles.
Shelf Life
24 months from date of manufacture when stored as directed
Sensitivity Notes
Sensitive to heat, light, and moisture. Keep sealed until use.
Compliance & Clinical Overview

Regulatory & Research Status

FDA Status
Not approved for human use.
WADA Classification
Prohibited under class S2 (Peptide Hormones, Growth Factors).
Clinical Trial Status
Multiple preclinical and clinical studies on growth hormone release, bone density, and body composition.
Published Studies
Multiple preclinical and clinical studies on growth hormone release, bone density, and body composition.
Research Disclaimer
For laboratory and research purposes only. Not intended for human consumption.

COA's (Certificate of Analysis)

Third Party Tested by Freedom Diagnostics
99.89%
Purity
Variant
Ipamorelin
Lot #
GL-2609-023
Labelled
10mg
Actual
10.25mg
Tested
9/14/2026
View COA
(opens in a new tab)
99.82%
Purity
Variant
Ipamorelin
Lot #
IPA10-GL01
Labelled
10mg
Actual
10.27mg
Tested
6/24/2026
View COA
(opens in a new tab)

Frequently Asked Questions

Common questions about Ipamorelin research